Market Overview

Citigroup Upgrades Acorda Therapeutics, Inc. to Buy, Raises PT to $33.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ACOR

DateFirmActionFromTo
May 2014CitigroupMaintainsHold
Apr 2014Canaccord GenuityInitiates Coverage onHold
Apr 2014FBR CapitalUpgradesMarket PerformOutperform

View More Analyst Ratings for ACOR
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (ACOR)

Around the Web, We're Loving...

Get Benzinga's Newsletters